These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28977747)

  • 1. Enhanced Class I Tumor Antigen Presentation via Cytosolic Delivery of Exosomal Cargos by Tumor-Cell-Derived Exosomes Displaying a pH-Sensitive Fusogenic Peptide.
    Morishita M; Takahashi Y; Nishikawa M; Ariizumi R; Takakura Y
    Mol Pharm; 2017 Nov; 14(11):4079-4086. PubMed ID: 28977747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA.
    Morishita M; Takahashi Y; Matsumoto A; Nishikawa M; Takakura Y
    Biomaterials; 2016 Dec; 111():55-65. PubMed ID: 27723556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of tissue distribution of the B16BL6-derived exosomes using a streptavidin-lactadherin fusion protein and iodine-125-labeled biotin derivative after intravenous injection in mice.
    Morishita M; Takahashi Y; Nishikawa M; Sano K; Kato K; Yamashita T; Imai T; Saji H; Takakura Y
    J Pharm Sci; 2015 Feb; 104(2):705-13. PubMed ID: 25393546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes.
    Nakase I; Futaki S
    Sci Rep; 2015 May; 5():10112. PubMed ID: 26011176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA Polyplexes with Post-Conjugated GALA Peptides Efficiently Target, Transfect, and Activate Antigen Presenting Cells.
    Lou B; De Koker S; Lau CYJ; Hennink WE; Mastrobattista E
    Bioconjug Chem; 2019 Feb; 30(2):461-475. PubMed ID: 30188694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.
    Miura N; Akita H; Tateshita N; Nakamura T; Harashima H
    Mol Ther; 2017 Apr; 25(4):1003-1013. PubMed ID: 28236573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Localization of Antigen Proteins in Antigen-Loaded Exosomes on Efficiency of Antigen Presentation.
    Arima Y; Liu W; Takahashi Y; Nishikawa M; Takakura Y
    Mol Pharm; 2019 Jun; 16(6):2309-2314. PubMed ID: 30908053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells.
    Mallegol J; Van Niel G; Lebreton C; Lepelletier Y; Candalh C; Dugave C; Heath JK; Raposo G; Cerf-Bensussan N; Heyman M
    Gastroenterology; 2007 May; 132(5):1866-76. PubMed ID: 17484880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73.
    Théry C; Regnault A; Garin J; Wolfers J; Zitvogel L; Ricciardi-Castagnoli P; Raposo G; Amigorena S
    J Cell Biol; 1999 Nov; 147(3):599-610. PubMed ID: 10545503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive.
    Kim SH; Bianco N; Menon R; Lechman ER; Shufesky WJ; Morelli AE; Robbins PD
    Mol Ther; 2006 Feb; 13(2):289-300. PubMed ID: 16275099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
    Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
    Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.
    Nakamura T; Moriguchi R; Kogure K; Shastri N; Harashima H
    Mol Ther; 2008 Aug; 16(8):1507-14. PubMed ID: 18560420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting cross-presentation of tumor antigen in human DC.
    Faure F; Mantegazza A; Sadaka C; Sedlik C; Jotereau F; Amigorena S
    Eur J Immunol; 2009 Feb; 39(2):380-90. PubMed ID: 19130478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides.
    Laus R; Graddis TJ; Hakim I; Vidovic D
    Nat Biotechnol; 2000 Dec; 18(12):1269-72. PubMed ID: 11101805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A2.1/K(b) transgenic murine dendritic cells transduced with an adenovirus encoding human gp100 process the same A2.1-restricted peptide epitopes as human antigen-presenting cells and elicit A2.1-restricted peptide-specific CTL.
    Yang S; Linette GP; Longerich S; Roberts BL; Haluska FG
    Cell Immunol; 2000 Aug; 204(1):29-37. PubMed ID: 11006015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic targeting of macromolecules using a pH-dependent fusogenic peptide in combination with cationic liposomes.
    Kobayashi S; Nakase I; Kawabata N; Yu HH; Pujals S; Imanishi M; Giralt E; Futaki S
    Bioconjug Chem; 2009 May; 20(5):953-9. PubMed ID: 19388672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity.
    Cafri G; Sharbi-Yunger A; Tzehoval E; Alteber Z; Gross T; Vadai E; Margalit A; Gross G; Eisenbach L
    Mol Ther; 2015 Aug; 23(8):1391-1400. PubMed ID: 25997427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.